Clinical Translation and Safety Regulation of Nanobiomaterials

Zhao, Ruibo; Keen, Lawrence Jordan; Kong, Xiangdong

doi:10.1002/9783527698646.ch19

Search citation statements

Order By: Relevance

Paper Sections

Select...

Progress and Advancements1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 102 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Building trust and acceptance requires open communication; therefore, transparency and communication with the patients, healthcare professionals, and the general public regarding nanocomposite-based medicines’ development and potential hazards. 170 The regulatory framework for nanocomposites in clinical translation is complicated, but it is critical for guaranteeing the safety and efficacy of these exciting novel medicines. Researchers and developers can boost the likelihood of successful clinical translation and deliver the benefits of nanocomposite-based drugs to patients by proactively addressing these factors and collaborating with regulatory regulators.…”

Section: Progress and Advancementsmentioning

confidence: 99%